STING1 and Parkinson disease: These results demonstrate that STING, as a novel downstream factor of DJ1-Nrf2 pathway, mediates the anti-neuroinflammatory actions of WA, revealing that STING may be a novel therapeutic target to mitigate PD-like symptoms.